1 / 72

IMMUNITY MEDIATED BY B LYMPHOCYTES AND ANTIBODIES

IMMUNITY MEDIATED BY B LYMPHOCYTES AND ANTIBODIES. IMMUNITY MEDIATED BY B LYMPHOCYTES AND ANTIBODIES. B lymphocytes recognize extracellular pathogens and toxins transported to secondary lymphoid tissues Recognition stimulates proliferation and differentiation into

tyanne
Download Presentation

IMMUNITY MEDIATED BY B LYMPHOCYTES AND ANTIBODIES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. IMMUNITY MEDIATED BY B LYMPHOCYTES AND ANTIBODIES

  2. IMMUNITY MEDIATED BY B LYMPHOCYTES AND ANTIBODIES • B lymphocytes recognize extracellular pathogens and toxins transported to secondary lymphoid tissues • Recognition stimulates proliferation and differentiation into • Plasma cells and memory B cells • B lymphocytes generally require help from activated T lymphocytes for differentiation into plasma cells • Plasma cells produce antibodies

  3. ACTIVATION OF B LYMPHOCYTES • Begins with antigen binding by receptors resulting in crosslinking of receptors • Clustering and aggregation of receptors activates • Tyrosine kinases • Tyrosine kinases phosphorylates Ig-alpha and Ig-beta proteins initiating intracellular signaling • Additional signals are required and provided by • B cell co-receptor • CD4 TH2 lymphocytes

  4. Figure 7-2 part 1 of 2

  5. Figure 7-2 part 2 of 2

  6. SIGNAL ENHANCEMENT BY B CELL CO-RECEPTOR • B cell co-receptor is complex of 3 proteins • CD21 [Complement receptor 2 (CR2)] • Binds to complement on pathogen • CD19 • CD81 • Signal enhancement results from juxtaposition of receptor and co-receptor • 1,000 to 10,000 X • Additional signals required depending on nature of antigen and provided by CD4 TH2 cells

  7. Figure 7-3

  8. FINAL OUTCOME OF B CELL ACTIVATION • Proliferation and differentiation of B cells into antibody producing plasma cells • Morphology of B cells and plasma cells • B cells • Large nucleus and small cytoplasm • Plasma cells • Large nucleus and large cytoplasm packed with ER

  9. THE NATURE OF ANTIGENS AND THE ANTIBODY RESPONSE • Thymus independent antigens (TI antigens) • Activate naïve B cells without help from CD4 cells • Classification into • TI-1 antigens (Lipopolysaccharides) • TI-2 antigens (Polysaccharides) • Minority of antibody production • Thymus dependent antigens (TD antigens) • Activation of naïve B cells requires help from CD4 cells • Majority of antibody production

  10. THYMUS INDEPENDENT ANTIGENS AND ANTIBODY PRODUCTION • TI-1 antigens • Lipopolysaccharide of gram-negative bacteria • Stimulate production of IgM only • LPS specific activation • LPS non-specific co-activation • Repeating epitopes not required • TI-2 antigens • Polysaccharides and proteins of bacteria • Stimulate production predominately of IgM • Repeating epitopes required

  11. Figure 7-5

  12. MECHANISM OF CD4 T CELL AND B CELL INTERACTION TO TD ANTIGENS • TD antigens transported to secondary lymphoid tissues for meeting with CD4 T cells and B cells • CD4 T cells are activated in T cell zone by APC • B cells enter T cell zone and bind same antigen • Antigen bound to B cell is internalized by • Receptor mediated endocytosis

  13. MECHANISM OF CD4 T CELL AND B CELL INTERACTION TO TD ANTIGENS • Antigen is processed and presented on B cell surface with MHC class II molecules • T cell and B cell interact via CD40L and CD40 • T cell produce cytokine (interleukin-4) which activates B cell • Cognate interaction • Interaction of B and T cells specific for same antigen

  14. COGNATE INTERACTION OF CD4 TH2 CELLS AND B CELLS • CI results in primary focus of B lymphoblasts in T cell area • Some B lymphoblasts move to medullary cords and differentiate into plasma cells • IL-5 and IL-6 from TH2 cells • Some B lymphoblasts move to primary follicles and differentiate into centroblasts • Centroblasts proliferate and follicle changes morphology • Germinal center

  15. GERMINAL CENTERS IN SECONDARY LYMPHOID TISSUES • Mantle zone • Resting B cells present in follicle prior to arrival of activated B cells and T cells • Light zone • Non-dividing centrocytes associated with • Follicular dentritic cells • Stromal cells of lymphoid follicles • Dark zone • Proliferating centroblasts

  16. GERMINAL CENTERS IN SECONDARY LYMPHOID TISSUES • Site for somatic hypermutation and affinity maturation • Initiated by cytokines of T cells • Begins with centroblasts in dark zone • Results in centrocytes with mutated receptors in light zone • B cells (centrocytes) which undergo somatic hypermutation • Produce receptor with range of affinities • Highest affinity receptors are selected • Must bind antigen or face apoptosis • Antigen provided by follicular dentritic cells

  17. PRESENTATION OF ANTIGEN BY FDC’S • Follicular dentritic cells (FDC’s) • Bind antigen in form of immune complexes • Bound immune complexes are not internalized and become clustered as • Iccosomes (Immune complex coated bodies) • Iccosomes are shed from FDC’s and taken up by centrocytes • Centrocytes must obtain, internalize and present antigen for differentiation into plasma cells

  18. Figure 7-10

  19. COMPARISON OF RESTING B CELLS AND PLASMA CELLS • Differentiation based on intrinsic and inducible properties • Intrinsic • Surface IG • Surface MHC class II molecules • High rate of antibody secretion • Inducible • Growth • Somatic hypermutation • Isotype switching

  20. ISOTYPE SWITCHING IN B CELLS • Takes place primarily in germinal centers • Determined by • Cognate interaction with CD4 T cells • Induction requires CD40L to CD40 • T cell cytokines • Induction or inhibition of isotypes • Hyper-IgM Syndrome • Genetic immunodeficiency from no CD40L • B cells cannot switch isotypes • No response to TD antigens

  21. GENERAL EFFECTOR FUNCTIONS OF ANTIBODIES • IgM • Protection of blood • IgG and IgA (monomeric) • Protection of blood and extracellular fluids • IgA (dimeric) • Protection mucous membranes and secretions • IgE • Protection of connective tissues

  22. PROTECTION OF BLOOD BY IgM ANTIBODIES • Primary function • Early protection against blood-borne pathogens • Characteristics • First antibody produced • Secreted form is pentamer with 10 binding sites • Penetration of tissue fluids is limited • Phagocytic cells have no IgM Fc receptors • Fc region can bind complement

  23. PROTECTION OF MUCOUS MEMBRANES BY DIMERIC IgA • Dimeric IgA made by plasma cells in mucosal-associated lymphoid tissues • GALT and BALT • Dimeric IgA transfer to epithelial surface • Transcytosis • Receptor mediated transport of macromolecules across epithelial cells • Mechanism of transcytosis • Binding to poly-Ig receptor on basolateral epithelium • Endocytotic vesicle transport to apical epithelium • Protease cleavage of receptor to secretory piece

  24. IgG TRANSPORT FROM BLOOD TO EXTRACELLULAR FLUIDS • Transport mediated by endothelial receptor • Brambell receptor (FcRB) • Structure of receptor • Similar to MHC class I molecule • Mechanism • Binding to FcRB on apical endothelium • Endocytotic vesicle transport to basolateral endothelium

  25. ANTIBODIES PROTECTING FETUS AND NEWBORN • IgG • Protects fetus and newborn • Maternal circulation to fetal circulation • Transfer across placenta mediated by FcRB • IgG levels similar in mothers and newborns • IgA • Protects GI tract of newborn • Transfer by breast milk • Dimeric form (IgA2 subclass)

  26. DISTRIBUTION OF ANTIBODIES IN HUMAN BODY • Plasma • IgM, IgG and IgA (monomeric) • Extracellular fluids • IgG and IgA (monomeric) • Mucous membranes and secretions • IgA (dimeric) • Connective tissues • IgE

  27. ANTIBODIES PROTECT AGAINST BACTERIAL EXOTOXINS • Number of bacteria cause disease by secreting exotoxins • Many toxins have receptor-binding and toxic functions on separate polypeptide chains • Exotoxin disease prevented by antibodies that block toxin binding • Neutralizing anitbodies • Antibodies raised by vaccination against toxins using • Toxoids (modified toxins)

More Related